Showing 341 - 360 of 1109 results
ANSTO’s radioanalytical facilities are recognised internationally and have extensive experience in the measurement of radioactivity from a wide variety of matrices. Our primary radoianalytical techniques include gamma spectrometry and alpha spectrometry.
The new Micro Computed Tomography (MCT) beamline is the first instrument to become operational as part of the $94 million Project BRIGHT program, which will see the completion of eight new beamlines at ANSTO’s Australian Synchrotron.
A new radiocarbon dating facility opened at the University of New South Wales (UNSW) will complement the extensive radiocarbon facilities at ANSTO’s world-leading Centre for Accelerator Science
You are invited to submit to the various awards from ANSTO, User Advisory Committee (UAC) and Australian Neutron Beam User Group (ANBUG).
Roles at ANSTO:
Develop and Maintain SIKA instrument control software
Mia is in her second year of Mechatronics Engineering at the University of Wollongong. She has worked at ANSTO, in the first cohort of the engineering cadetship program, since July 2024.
Our dedicated mineralogists provide specialised knowledge on the mineralogy of ores/concentrates and the wide variety of solids and residues typically generated in hydromet processes. We have well-equipped facilities that can handle a diverse range of samples, particularly those containing elevated concentrations of uranium and thorium.
Southern Sydney Innovation Network (SSIN) is calling all innovators, creators, ideas people and entrepreneurs in Southern Sydney to become part of this community driven, not-for-profit group supporting startups and entrepreneurs.
Since the discovery of superconducting Caintercalated graphite (CaC6) the intercalation of epitaxial graphene on SiC(0001) with Ca has been studied extensively in order to achieve superconductivity.
NSW grants bolster additive manufacturing and groundwater processing capabilities.
The first demonstration of reversible symmetry lowering phase transformation with heating.
Shift in the treatment of blood cancers taking place.
Radioisotopes are widely used in medicine, industry, and scientific research. New applications for radioisotopes are constantly being developed.
X-ray crystallography at the Australian Synchrotron contributed to major research findings.
ANSTO scientists are participating investigators in three new ARC Industrial Transformation Training Centres, recently announced by the Government.
Meeting of minds about potential next-generation cancer treatment for Australians
This program uses ANSTO’s nuclear capabilities to identify, quantify, and monitor the mechanisms which cause, or influence the development and progression of chronic diseases.